- Home
- CDTG vs SCNX Comparison
CDTG vs SCNX Comparison
Compare CDTG & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTG
- SCNX
- Stock Information
- Founded
- CDTG 2012
- SCNX 2010
- Country
- CDTG China
- SCNX United States
- Employees
- CDTG N/A
- SCNX N/A
- Industry
- CDTG
- SCNX Other Pharmaceuticals
- Sector
- CDTG
- SCNX Health Care
- Exchange
- CDTG NYSE
- SCNX Nasdaq
- Market Cap
- CDTG 34.6M
- SCNX 33.6M
- IPO Year
- CDTG 2024
- SCNX 2020
- Fundamental
- Price
- CDTG $1.33
- SCNX $1.19
- Analyst Decision
- CDTG
- SCNX
- Analyst Count
- CDTG 0
- SCNX 0
- Target Price
- CDTG N/A
- SCNX N/A
- AVG Volume (30 Days)
- CDTG 94.7K
- SCNX 2.6M
- Earning Date
- CDTG 04-03-2025
- SCNX 03-18-2025
- Dividend Yield
- CDTG N/A
- SCNX N/A
- EPS Growth
- CDTG N/A
- SCNX N/A
- EPS
- CDTG 0.72
- SCNX 3.55
- Revenue
- CDTG $31,432,824.00
- SCNX N/A
- Revenue This Year
- CDTG N/A
- SCNX $1,085.75
- Revenue Next Year
- CDTG N/A
- SCNX N/A
- P/E Ratio
- CDTG $1.82
- SCNX $0.53
- Revenue Growth
- CDTG N/A
- SCNX 166.67
- 52 Week Low
- CDTG $1.16
- SCNX $1.13
- 52 Week High
- CDTG $4.64
- SCNX $33.28
- Technical
- Relative Strength Index (RSI)
- CDTG N/A
- SCNX N/A
- Support Level
- CDTG N/A
- SCNX N/A
- Resistance Level
- CDTG N/A
- SCNX N/A
- Average True Range (ATR)
- CDTG 0.00
- SCNX 0.00
- MACD
- CDTG 0.00
- SCNX 0.00
- Stochastic Oscillator
- CDTG 0.00
- SCNX 0.00
About CDTG CDT ENVIRONMENTAL TECH INV HLDG LTD
CDT Environmental Technology Investment Holdings Ltd is a waste treatment company. The company generates revenue through the design, development, manufacture, sales, installation, operation and maintenance of sewage treatment systems and by providing sewage treatment services. It engages in two business lines namely, rural sewage treatment and septic tank treatment in both urban and rural areas.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.